Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01072448 · ClinicalTrials.gov registry record · Phase 3
12-week Efficacy of Indacaterol
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 323
- Enrollment target
NCT01072448 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 323 participants.
The verdict
NCT01072448, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 323 participants
- Enrollment target
Study Summary
This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.
Interventions
- DRUG Placebo to indacaterol
- DRUG Indacaterol 75 μg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01072448
The ClinicalTrials.gov registry entry for NCT01072448 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo to indacaterol is the first listed.
NCT01072448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01072448 about?
NCT01072448 is a clinical study titled "12-week Efficacy of Indacaterol". This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.
What is the current status of trial NCT01072448?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 323 participants. The study started on 2010-01. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01072448?
The interventions under investigation include: Placebo to indacaterol (DRUG), Indacaterol 75 μg (DRUG).
Who is sponsoring clinical trial NCT01072448?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.